Information från ABG Sundal Collier

Här finner du information kring börsens mindre och medelstora bolag. Avsändare är ABG Sundal Collier, innehållet är inte skapat av placera.nu:s redaktion.

« Tillbaka

Alligo - Softer growth, but margin recovery continues

08 juli 2026

<a id="bm-comp-c76f3c12-7b3f-416f-a26c-8bc9ee4720bf" name="bm-comp-c76f3c12-7b3f-416f-a26c-8bc9ee4720bf" class="BMCustomAnchor"></a><table><tr><td bm-component-id="c76f3c12-7b3f-416f-a26c-8bc9ee4720bf" style="vertical-align: top; width:100.000000%;"><ul><li>We see 1% organic growth in Q2 as the winter weather boost fades</li><li>Cost savings and FX lift adj. EBITA margin 1.4pp y-o-y to 7.2%</li><li>New CEO Samuel Alteborg took over the helm on 1 June</li></ul></td></tr></table><a id="bm-comp-7550d20c-0897-4176-909c-33d8cdcacaf0" name="bm-comp-7550d20c-0897-4176-909c-33d8cdcacaf0" class="BMCustomAnchor"></a><table><tr><td bm-component-id="7550d20c-0897-4176-909c-33d8cdcacaf0" style="vertical-align: top; width:100.000000%;"><h3 class="bm-h3">Q2 expectations</h3><p>The strong Q1 organic growth of 5% was boosted by cold winter weather, which naturally did not recur in Q2. With underlying demand stable q-o-q, we forecast organic growth of 1%, with FX and bolt-on M&amp;A lifting total growth to around 4%. The positive gross margin trend should persist, driven by own-brand sales and favourable FX, and we forecast 41.5% (40.1%). Together with the final quarter of benefit from the H2'25 cost savings, this takes the adj. EBITA margin to 7.2% (5.8%). We expect the Finland restructuring to continue, but at a lower one-off cost than in Q1, at around SEK -4m.</p><h3 class="bm-h3">Estimate changes</h3><p>We make only very minor changes, leaving our '26e-'28e estimates broadly unchanged. Sweden continues to develop well, while the Finland restructuring keeps weighing somewhat on the near-term results, albeit with lower one-off costs in Q2 than in Q1.</p><h3 class="bm-h3">Outlook and valuation</h3><p>Samuel Alteborg took over as CEO on 1 June, having previously led rental company Cramo, and we look forward to hearing his strategy for Alligo after the summer. Our early impression is that his experience is highly relevant and that near-term continuity is intact. Our overall view is unchanged: Alligo should reap the rewards of an improving market over the coming years, with organic growth driving further margin recovery and, in turn, substantial adj. EPS growth of around 25% in '26e. The share is trading at a '26e-'28e P/E of 12-9x, and we reiterate our fair value range of SEK 120-190.</p></td></tr></table>

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-08-13 NYAB - Strong earnings beat, +27% vs cons NYAB Analys
2026-08-12 G5 Entertainment - Cost cuts to support earnings ... G5 Entertai.. Analys
2026-08-12 Ferronordic - Three for three Ferronordic Analys
2026-08-12 G5 Entertainment - Larger cost savings offsetting... G5 Entertai.. Analys
2026-08-12 Ferronordic - Earnings beat across the board Ferronordic Analys
2026-08-11 OssDsign - Waiting for the growth to return OssDsign Analys
2026-08-11 Arctic Paper - Pulp beats paper II Arctic Paper Analys
2026-08-11 Generic - The growth journey continues Generic Analys
2026-08-10 Donkey Republic - Q2 likely to confirm strong gro... Donkey Repu.. Analys
2026-08-06 Medicover - Divests Medicover Hospitals India Medicover Analys
2026-07-30 Byggmästaren - Private assets strong, but Green s... Byggmästaren Analys
2026-07-30 Catella - Recovery gradually taking shape Catella Analys
2026-07-24 Cavotec - Low-margin legacy orders weigh on Q2 Cavotec Analys
2026-07-24 Cavotec - P&M order momentum sustained Cavotec Analys
2026-07-22 Inission - Strong trend to continue Inission Analys
2026-07-22 SinterCast - Q2 still tough, but we see tailwinds... SinterCast Analys
2026-07-22 Medicover - No symptoms of surprise in Q2 Medicover Analys
2026-07-22 Ework Group - Cautious optimism Ework Group Analys
2026-07-22 Donkey Republic - Helsinki deal offers further de... Donkey Repu.. Analys
2026-07-22 Medicover - In line report, reiterated targets Medicover Analys